Skip to Main Content

Paper Details

Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer.
Breast Cancer Research and Treatment
6
2022
HER2, MBC, Patients, localized breast cancer, metastatic breast cancer, negative subtype, patient, patients, triple-, triple-negative breast cancers
Author NameAffiliation
Tomás PascualHospital Universitario
Tomás PascualUNC Lineberger Comprehensive Cancer Center
Amy WhelessUNC Lineberger Comprehensive Cancer Center
Charles M Perou
Lisa A CareyUniversity of North Carolina at Chapel Hill
  • 1 - 5

Datasets

Release 1.2